Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm?

Hurlstone, David P.; Sanders, David S.; Atkinson, Robert; Hunter, Michael D.; McAlindon, M. E.; Lobo, A. J.; Cross, Simon S.; Thomson, Mike
June 2007
Gut;Jun2007, Vol. 56 Issue 6, p838
Academic Journal
Background: The potential of endoscopic mucosal resection (EMR) for treating flat dysplastic lesions in chronic ulcerative colitis (CUC) has not been addressed so far. Historically, such lesions were referred for colectomy. Furthermore, there are only limited data to support endoscopic resection of exophytic adenoma- like mass (ALM) lesions in colitis. Aims: To evaluate the safety and clinical outcomes of patients with colitis undergoing EMR for Paris class 0-II and class I ALM compared with sporadic controls. Secondary aims were to re-evaluate the prevalence, anatomical ‘mapping’ and histopathological characteristics of both Paris class 0-II and class I lesions in the context of CUC. Methods: Prospective clinical, pathological and outcome data of patients with colitis-associated Paris class 0-II and Paris class I ALM treated with EMR (primary end points being colorectal cancer development, resection efficacy, metachronous lesion rates and post-resection recurrence rates) were compared with those of sporadic controls. Results: 204 lesions were diagnosed in 169 patients during the study period: 167 (82%) diagnosed at ‘entry’ colonoscopy, and 36 (18%) diagnosed at follow-up. 170 ALMs, 18 dysplasia-associated lesion masses (DALMs) and 16 cancers were diagnosed. A total of 4316 colonascopies were performed throughout the study period (median per patient: 6; range: 1–8). The median follow-up period for the complete cohort was 4.1 years (range: 3.6–5.21). 1675 controls were included from our prospective database of patients without CUC who had undergone EMR for sporadic Paris class 0-II and snare polypectomy of Paris type I lesions from 1998 onwards, and were considered to be at moderate to high lifetime risk of colorectal cancer. 3792 colonoscopies were performed throughout the study period in this group (median per patient: 4; range: 1–7). The median follow-up period was 4.8 years (range: 2.9–5.2). No statistically significant differences were observed between the CUC study group and controls with respect to age, sex, median number of colonoscopies per patient, median follow-up duration, post-resection complications, median lesional diameter or interval cancer rates. However, there was a significant between-group difference regarding the prevalence of Paris class 0-II lesions in the CUC group (82/155 (61%)) compared with controls (285/801 (35%); χ² = 31 .13; p<0.001). Furthermore, recurrence rates of lateral spreading tumours were higher in the colitis cohort (1/7 (14%)) than among controls (0/10 (0%); p=0.048 (95% CI 11.64% to 40.21%)). Conclusions: Flat DALM, similarly to Paris class I ALM, can be managed safely by EMR in CUC. A change in management paradigm to include EMR for the resection of Hat dysplastic lesions in selected cases is proposed.


Related Articles

  • Worsening Risk for the Development of Dysplasia or Cancer in Patients with Chronic Ulcerative Colitis. Lashner, Bret A.; Provencher, Kimberly S.; Bozdech, John M.; Brzezinski, Aaron // American Journal of Gastroenterology;Mar1995, Vol. 90 Issue 3, p377 

    Objectives: Patients with ulcerative colitis (UC) are at increased risk for developing dysplasia or cancer (neoplasia) and are usually offered colonoscopic surveillance to reduce their risk of cancer-related mortality. The causes of neoplasia may be related to features of UC (the extent,...

  • Delayed Perforation of the Cecum after Diagnostic Biopsy. Loggan, Michael; Moeller, Donald D. // American Journal of Gastroenterology;Dec1984, Vol. 79 Issue 12, p933 

    Colonoscopy is an important diagnostic study in monitoring patients with chronic ulcerative colitis for carcinoma and dysplasia (precancer). A 76-year-old woman with chronic ulcerative colitis of 13 years' duration underwent colonoscopy. Biopsies were obtained at 10-cm intervals throughout the...

  • DYSPLASIA IN ULCERATIVE COLITIS IS USUALLY VISIBLE AT COLONOSCOPY. Rutter, M.D.; Wilkinson, K.H.; Saunders, B.P. // Gut;Apr2003 Supplement 1, Vol. 52, pA4 

    Background and Aim: During colonoscopic surveillance for dysplasia in longstanding extensive ulcerative colitis (UC), multiple non-targeted "random" biopsies of colonic mucosa are advised, based on historical data suggesting dysplasia may only be detectable microscopically. We aimed to assess...

  • Is Surveillance Endoscopy Necessary after Colectomy in Ulcerative Colitis? Shuno, Yasutaka; Hata, Keisuke; Sunami, Eiji; Shinozaki, Masaru; Kawai, Kazushige; Kojima, Tetsu; Tsurita, Giichiro; Hiyoshi, Masaya; Tsuno, Nelson H.; Kitayama, Joji; Nagawa, Hirokazu // ISRN Gastroenterology;2011, Special section p1 

    The role of surveillance endoscopic followup in colectomized patients with long standing total colitis is controversial. Here, we aimed to clarify its usefulness for the early detection of dysplasia and cancer in this group of patients. Ninety-seven colectomised UC patients followedup by...

  • Adenocarcinoma in Strictures of Ulcerative Colitis without Antecedent Dysplasia by Colonoscopy. Reiser, Janet R.; Waye, Jerome D.; Janowitz, Henry D.; Harpaz, Noam // American Journal of Gastroenterology;Jan1994, Vol. 89 Issue 1, p119 

    We report three patients with chronic ulcerative colitis and colonic strictures that were found to harbor advanced adenocarcinomas despite previous endoscopic examinations that had failed to demonstrate dysplasia or carcinoma. This experience calls into question the reliability of endoscopic...

  • Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis. Ando, Takafumi; Nishio, Yuji; Watanabe, Osamu; Takahashi, Hironao; Maeda, Osamu; Ishiguro, Kazuhiro; Ishikawa, Daisuke; Ohmiya, Naoki; Niwa, Yasumasa; Goto, Hidemi; Rodrigo, Luis; Vandenplas, Yvan // World Journal of Gastroenterology;4/14/2008, Vol. 14 Issue 14, p2133 

    Ulcerative colitis (UC) is a chronic inflammatory bowel disorder characterized by exacerbations and remissions. Some UC patients remain refractory to conventional medical treatment while, in others, the effectiveness of drugs is limited by side-effects. Recently, cyclosporine and leukocyte...

  • Is Colonoscopy Alone Sufficient to Screen for Ulcerative Colitis-associated Colorectal Carcinoma? World J. Surg. Vol. 27, No. 5, May 2003. Bruewer, Matthias; Krieglstein, Christian F.; Utech, Markus; Bode, Marc; Rijcken, Emile; Anthoni, Christoph; Laukoetter, Mike G.; Schuermann, Guido; Senninger, Norbert // World Journal of Surgery;May2003, Vol. 27 Issue 5, p611 

    Patients with ulcerative colitis (UC) are at increased risk for colorectal carcinoma (CAC). Despite the fact that patients at risk are followed closely by colonoscopy to screen for dysplasia, the prevalence of CAC is still unacceptably high. The aim of this study was to evaluate the prevalence...

  • Conservative Management of Small Adenomata in Ulcerative Colitis. Medlicott, S. A. C.; Jewell, L. D.; Price, L.; Fedorak, R. N.; Sherbaniuk, R. W.; Urbanski, S. J. // American Journal of Gastroenterology;Nov1997, Vol. 92 Issue 11, p2094 

    Objective and Methods: Patients with chronic ulcerative colitis may develop colitis-related dysplasia and/or sporadic adenomata. Differentiating between these two processes is important because they may dictate different therapeutic approaches. Although distinguishing features of sporadic...

  • Physicians' Perceptions of Dysplasia and Approaches to Surveillance Colonoscopy in Ulcerative Colitis. Bernstein, Charles N.; Weinstein, Wilfred M.; Levine, Douglas S.; Shanahan, Fergus // American Journal of Gastroenterology;Dec1995, Vol. 90 Issue 12, p2106 

    Objective: Colonoscopic biopsy surveillance to detect dysplasia, defined as a neoplastic change of the epithelium without invasion into the lamina propria, in patients with ulcerative colitis has become a widespread practice. We undertook a survey study to determine physicians' perceptions of,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics